Abacavir Acebutolol Acetaminophen Acetylcysteine Acyclovir Albendazole Albuterol Alcohol Allopurinol Amiodarone Amlodipine Amoxicillin Amphotericin B Ampicillin Antacids Antipsychotics Apixaban Aspirin Atazanavir Atenolol Atorvastatin Atracurium Azathioprine Azithromycin Baclofen Beta Blockers Bumetanide Bupropion Buspirone Calcium gluconate Carbamazepine Cefazolin Cefepime Ceftriaxone Cephalexin Ciprofloxacin Cisplatin Clindamycin Clonazepam Clonidine Clopidogrel Cyclobenzaprine Cyclophosphamide Dabigatran Dalteparin Dexamethasone Digoxin Diltiazem Diphenhydramine Dobutamine Dopamine Doxycycline Enalapril Enoxaparin Epinephrine Epoetin alfa Escitalopram Esomeprazole Famotidine Fentanyl Ferrous sulfate Fluconazole Fluoroquinolones Fluoxetine Fluticasone Furosemide Gabapentin Gentamicin Haloperidol Heparin Hydralazine Hydrochlorothiazide Hydrocortisone Hydromorphone Ibuprofen Insulin glargine Insulin lispro Ipratropium Isoniazide Ketorolac Labetalol Lamotrigine Levofloxacin Levothyroxine Lidocaine Linezolid Lithium Lorazepam Losartan Magnesium sulfate Melatonin Mercaptopurine Meropenem Metformin Methadone Methocarbamol Methotrexate Methylprednisolone Metoclopramide Metoprolol Metronidazole Midazolam Morphine Naloxone Nitroglycerin Norepinephrine Ondansetron Pantoprazole Phenytoin Piperacillin-tazobactam Potassium chloride Prednisone Probenecid Propofol Quetiapine Ramipril Rifampin Sertraline Simvastatin Spironolactone SSRI Tramadol Vancomycin Verapamil Warfarin
Abacavir Pharmacokinetic Alters methadone metabolism ↓ Methadone efficacy → withdrawal symptoms Monitor and adjust methadone dose
Acebutolol Pharmacodynamic Additive negative chronotropic effects Bradycardia, AV block Monitor heart rate and ECG
Acetaminophen - Acetaminophen Warfarin Pharmacodynamic ↑ INR with chronic use ↑ Bleeding risk Monitor INR closely if used long-term
Acetylcysteine
Acyclovir Pharmacokinetic ↓ Renal tubular secretion ↑ Acyclovir toxicity risk Adjust dose if renal impairment
Albendazole Pharmacokinetic ↑ Hepatic enzyme induction ↓ Albendazole levels Monitor efficacy or increase dose
Albuterol
Alcohol Alcohol Metronidazole Pharmacodynamic Disulfiram-like reaction Flushing, vomiting, hypotension Avoid concurrent use
Allopurinol Pharmacodynamic:
↑ Risk of rash
Severe skin reactions (SJS/TEN)
Avoid combination or monitor closely
Pharmacokinetic Inhibits xanthine oxidase → ↑ active metabolite Severe bone marrow suppression Reduce azathioprine dose by 75% Pharmacokinetic Inhibits xanthine oxidase → ↑ mercaptopurine toxicity Severe myelosuppression Reduce mercaptopurine dose
Amiodarone Pharmacokinetic P-gp inhibition ↑ Dabigatran levels → bleeding risk Monitor for bleeding; consider dose adjustment PharmacokineticDigoxin clearance Digoxin toxicity (arrhythmias) Monitor digoxin levels, reduce dose if needed Pharmacokinetic CYP2C9 inhibition ↑ Phenytoin toxicity Monitor phenytoin levels Pharmacokinetic CYP3A4 inhibition Rhabdomyolysis Limit simvastatin dose or use alternative statin Pharmacokinetic CYP2C9 inhibition ↑ INR, bleeding risk Reduce warfarin dose; monitor INR closely
Amlodipine
Amoxicillin
Amphotericin B Pharmacodynamic Additive nephrotoxicity Kidney damage Monitor renal function and digoxin levels
Ampicillin Pharmacodynamic:
↑ Risk of rash
Severe skin reactions (SJS/TEN)
Avoid combination or monitor closely
Antacids Pharmacokinetic Chelation ↓ absorption ↓ Antibiotic efficacy Separate doses by 2–4 hours Pharmacokinetic ↓ absorption due to pH changes ↓ Isoniazid efficacy Separate administration times Pharmacokinetic ↑ gastric pH ↓ absorption ↓ Ketoconazole efficacy Separate administration times
Antipsychotics
Apixaban Major interaction: Additive bleeding risk (GI & systemic) due to NSAID-induced platelet inhibition + apixaban anticoagulation. Avoid if possible; use lowest NSAID dose, add gastroprotection, monitor for bleeding
Aspirin
Atazanavir
Atenolol
Atorvastatin
Atracurium
Azathioprine Pharmacokinetic Inhibits xanthine oxidase → ↑ active metabolite Severe bone marrow suppression Reduce azathioprine dose by 75%
Azithromycin
Baclofen
Beta Blockers
Bumetanide
Bupropion
Buspirone
Calcium gluconate
Carbamazepine
Cefazolin
Cefepime
Ceftriaxone
Cephalexin
Ciprofloxacin
Cisplatin
Clindamycin
Clonazepam
Clonidine
Clopidogrel
Cyclobenzaprine
Cyclophosphamide
Dabigatran Pharmacokinetic P-gp inhibition ↑ Dabigatran levels → bleeding risk Monitor for bleeding; consider dose adjustment
Dalteparin Major interaction: Avoid. Ketorolac inhibits platelets and increases GI bleeding; dalteparin provides anticoagulation → strong additive bleeding risk (GI, surgical, spinal). Use alternatives (acetaminophen/opioids).
Dexamethasone Pharmacokinetic ↑ Hepatic enzyme induction ↓ Albendazole levels Monitor efficacy or increase dose
Digoxin PharmacokineticDigoxin clearance Digoxin toxicity (arrhythmias) Monitor digoxin levels, reduce dose if needed Pharmacodynamic Additive nephrotoxicity Kidney damage Monitor renal function and digoxin levels
Diltiazem
Diphenhydramine
Dobutamine
Dopamine
Doxycycline
Enalapril
Enoxaparin
Epinephrine
Epoetin alfa
Escitalopram
Esomeprazole
Famotidine
Fentanyl
Ferrous sulfate
Fluconazole
Fluoroquinolones Pharmacokinetic Chelation ↓ absorption ↓ Antibiotic efficacy Separate doses by 2–4 hours
Fluoxetine
Fluticasone
Furosemide
Gabapentin
Gentamicin
Haloperidol
Heparin
Hydralazine
Hydrochlorothiazide
Hydrocortisone
Hydromorphone
Ibuprofen Major interaction: Additive bleeding risk (GI & systemic) due to NSAID-induced platelet inhibition + apixaban anticoagulation. Avoid if possible; use lowest NSAID dose, add gastroprotection, monitor for bleeding
Insulin glargine
Insulin lispro
Ipratropium
Isoniazide Pharmacokinetic ↓ absorption due to pH changes ↓ Isoniazid efficacy Separate administration times
Ketoconazole Pharmacokinetic ↑ gastric pH ↓ absorption ↓ Ketoconazole efficacy Separate administration times
Ketorolac Major interaction: Avoid. Ketorolac inhibits platelets and increases GI bleeding; dalteparin provides anticoagulation → strong additive bleeding risk (GI, surgical, spinal). Use alternatives (acetaminophen/opioids)
Labetalol
Lamotrigine
Levofloxacin Major interaction: Additive QT prolongation → ↑ risk of torsades. Avoid combination if possible; monitor ECG & electrolytes if used together
Levothyroxine
Lidocaine
Linezolid
Lithium
Lorazepam
Losartan
Magnesium sulfate
Melatonin
Mercaptopurine Pharmacokinetic Inhibits xanthine oxidase → ↑ mercaptopurine toxicity Severe myelosuppression Reduce mercaptopurine dose
Meropenem
Metformin
Methadone Pharmacokinetic Alters methadone metabolism ↓ Methadone efficacy → withdrawal symptoms Monitor and adjust methadone dose
Methocarbamol
Methotrexate
Methylprednisolone
Metoclopramide
Metoprolol
Metronidazole Pharmacodynamic Disulfiram-like reaction Flushing, vomiting, hypotension Avoid concurrent use
Midazolam
Morphine
Naloxone
Nitroglycerin
Norepinephrine
Ondansetron
Pantoprazole
Phenytoin Pharmacokinetic CYP2C9 inhibition ↑ Phenytoin toxicity Monitor phenytoin levels
Piperacillin-tazobactam
Potassium chloride
Prednisone
Probenecid Pharmacokinetic ↓ Renal tubular secretion ↑ Acyclovir toxicity risk Adjust dose if renal impairment
Propofol
Quetiapine Major interaction: Additive QT prolongation → ↑ risk of torsades. Avoid combination if possible; monitor ECG & electrolytes if used together
Ramipril
Rifampin
Sertraline
Simvastatin Pharmacokinetic CYP3A4 inhibition Rhabdomyolysis Limit simvastatin dose or use alternative statin
Spironolactone
SSRI
Tramadol
Vancomycin
Verapamil Pharmacodynamic Additive negative chronotropic effects Bradycardia, AV block Monitor heart rate and ECG
Warfarin Pharmacodynamic ↑ INR with chronic use ↑ Bleeding risk Monitor INR closely if used long-term Pharmacokinetic CYP2C9 inhibition ↑ INR, bleeding risk Reduce warfarin dose; monitor INR closely
WordPress Data Table